Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator
(Q71620957)
scientific article published on 01 May 1994
scientific article published on 01 May 1994
Language: